ArticleVeterinary dermatology2026
Development of a Four-Language Questionnaire to Investigate Environmental Risk Factors for the Development of Canine Atopic Dermatitis and to Monitor Disease Course and Progression.
Article in Veterinary dermatology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
12 authors.
Funding
Abstract
backgroundThe chronic and multifactorial character of canine atopic dermatitis (cAD) often leads to poor disease control and treatment dissatisfaction. Environmental factors are likely to contribute to the disease development and may play a more important role than assumed previously. This opens new research directions that require an appropriate tool to obtain useful data from large representative study populations. HYPOTHESIS/
objectivesA tool such as a questionnaire is suitable for obtaining high-quality data to investigate the pathogenesis of cAD and monitor the disease. MATERIALS AND
methodsTo assure the tool's validity and reliability, the development process of this four-language questionnaire (original language German) included two pilot tests (with owners' interviews and questionnaire evaluation sheets), test-retest assessment, content validity evaluation and a structured translation and back-translation into three languages (English, Italian and French).
resultsThe development process took place between June 2024 and December 2024. The preliminary questionnaire comprised 107 questions. The pilot tests (round 1 = four participants, round 2 = two participants) resulted in a revision of 31 questions and the deletion of three. The test-retest assessment revealed an Intraclass Correlation Coefficient of 0.80. The panel of (six) experts evaluated the questionnaire with a content validity index of 0.99. The translation and back-translation process revealed that only minor adjustments were sufficient to guarantee the validity and reliability across languages. CONCLUSIONS AND CLINICAL RELEVANCE: The comprehensive development process ensures high validity and reliability of the questionnaire, indicating that such a process can not only positively impact the quality of the developed tool, but also create a reliable basis for the generation of accurate and less biased data.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.